The North American vasovagal pacemaker study (VPS) §§A list of members appears in the Appendix.22Editorials published in Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.-Reference-Cited by-同舟云学术

The North American vasovagal pacemaker study (VPS) §§A list of members appears in the Appendix.22Editorials published in Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.

Published:1999-01 Issue:1 Volume:33 Page:16-20
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Connolly StuartJ,Sheldon Robert,Roberts RobinS,Gent Michael

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference15 articles.

1. Cardiac pacing for the prevention of recurrent vasovagal syncope;Benditt;Ann Intern Med,1995

2. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole;Sra;N Engl J Med,1993

3. Dual chamber pacing aborts vasovagal syncope induced by head-up 60° tilt;Fitzpatrick;Pacing Clin Electrophysiol,1991

4. Comparison of single and dual chamber pacing techniques in prevention of upright tilt induced vasovagal syncope;Samoil;Eur JCPE,1993

5. Cardiac pacing does not improve orthostatic tolerance in patients with vasovagal syncope;el-Bedawi;Clin Auton Res,1994

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Placebo Control and Blinding in Randomized Trials of Procedural Interventions;JAMA Surgery;2024-07-01

2. Therapeutic options for neurocardiogenic syncope: a meta-analysis of randomised trials with and without blinding;Open Heart;2024-06

3. How to perform cardioneuroablation for vasovagal syncope and functional bradycardia;Heart Rhythm;2024-01

4. Potential consequences of cardioneuroablation for vasovagal syncope: “A call for appropriately designed, sham-controlled clinical trials”;Heart Rhythm;2023-12

5. Cardioneuroablation for severe neurocardiogenic syncope;Revista Portuguesa de Cardiologia;2023-10